Forte Biosciences, Inc. 8-K

What Happened

• Forte Biosciences, Inc. (FBRX) filed a Current Report on Form 8-K (Item 2.02) to announce its results of operations and financial condition for the fourth quarter and fiscal year ended December 31, 2025.
• The company issued a press release dated March 31, 2026 reporting those financial results; the press release was furnished as Exhibit 99.1 to the 8-K filed April 1, 2026.

Key Details

• Filing: Form 8-K reporting results of operations and financial condition (Item 2.02).
• Press release date: March 31, 2026; furnished as Exhibit 99.1.
• Reporting period: Fourth quarter and fiscal year ended December 31, 2025.
• Technical exhibit: Interactive XBRL cover page included (Exhibit 104).

Why It Matters

• This 8-K is the company’s formal announcement of its recent quarterly and full-year financial results—investors should review the March 31 press release for revenue, net income/loss, cash position and any management commentary or guidance.
• Because the press release was furnished as an exhibit, it is the primary source of the reported figures; investors should consult the full press release and subsequent SEC filings (e.g., Form 10-K) for detailed financial statements and context before making decisions.